News Detail
New Delhi, 22 May 2024: Despite repeated requests and instructions from the Central drug regulator, almost 21 states and four Union Territories have not submitted any data in respect of spurious alert for the month of April, 2024, said the Central drug regulator, while announcing......
View Details
Source : Pharmabiz
Central drug regulator
spurious alert
CDSCO
DCGI
SLAs
NCT
rifaximin
Rifagut 400
Sun Pharma
dolutegravir
Instgra
Emcure Pharma
telmisartan
Telma AM
Glenmark Pharma
Naxdom Pure and Cure
Presef 200
ONDLS
Related News
- Cipla gets nod to market Afrezza insulin inhalation powder in India (12-12-2024)
- UK regulator probes anti-depressants safety alerts after suicide link (12-12-2024)
- Haryana Food Department to Crack Down on Fake Protein Supplements After Major Bust (12-12-2024)
- Drug inspector sentenced to 3-yr rigorous imprisonment (12-12-2024)
- 11.12 crore worth of short-shelf life medicines expired due to delayed supply to TNMSC: CAG Report (12-12-2024)
- Ayush Ministry amends D&C Act to add Homoeopathy, Sowa Rigpa books and Pharmacopoeias (12-12-2024)
- Construction of all three bulk drug parks are in progress: Ministry of chemicals (12-12-2024)
- Four-member gang nabbed for selling ‘Mephentermine Sulphate’ injections in Hyderabad (12-12-2024)
- Combining BCL-2 and BTK inhibitors shows promise in chronic lymphocytic leukemia (CLL) (11-12-2024)
- Punjab cop arrests man for narcotic drugs case, gets fined by court (11-12-2024)